Chinese biotech firms eye foreign pharma鈥檚 fat profits in weight loss drug market

By Eric Ng

Chinese biotech firms eye foreign pharma鈥檚 fat profits in weight loss drug market

When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due to hormonal imbalances that slowed her metabolism. She reached a peak weight of 100kg about a year ago, but has since lost 25kg.
The secret to losing a quarter of her weight? Chan, who asked not to be identified by her full name, was one of the city鈥檚 first 200 chronic obesity patients to receive access to a new weight loss drug, originally developed for diabetes. At a cost of HK$2,700…

Read More…